Asia Pacific Anti-Obesity Drugs Market Report 2024-2032

Asia Pacific anti-obesity drugs market is poised for growth, driven by the expansion of the global market, which was valued at USD 2.5 billion in 2023 and is projected to grow at a CAGR of 10.70% during the forecast period of 2024-2032.

亚太地区抗肥胖药物市场预计将迎来增长，这一趋势由全球市场的扩张所推动，该市场在2023年的价值达到25亿美元，并在2024-2032年预测期间预计将以10.70%的复合年增长率增长。